Difference between revisions of "Team:Linkoping Sweden/Description"

Line 28: Line 28:
 
</p>
 
</p>
 
</article>
 
</article>
<!--<div class="flex-text-30">
+
<div class="flex-text-30">
<a class="content-button" href="#"> Read more about alzheimer here </a>
+
<a class="content-button" href=""> Read more about alzheimer here </a>
</div>-->
+
</div>
 
</div>
 
</div>
 
 

Revision as of 09:06, 22 August 2017

Project description


The aim of the project is to optimize the expression of the proteins amyloid-beta and tau in the bacteria Escherichia coli. These proteins are known to be linked to the development of Alzheimer's disease, though the cause of the disease is still unknown [1]. They are both found in the brain in and around our neurons, and during Alzheimer's disease they accumulate to form plaques and tangles [3, 4]. Because these proteins are prone to misfolding and aggregate they are hard to study in a laboratory environment, which has slowed down research. It’s here our project comes in, trying to facilitate the production of these proteins.

To optimize the expression of the proteins we will be using chaperones. Chaperones are proteins that can help other proteins to fold into their native three-dimensional shape, by dissolving aggregates and guiding both unfolded and misfolded proteins to their correctly folded form. During our project we will be using four different chaperones and we will see how different combinations of these affect the expression of Amyloid-beta and Tau respectively.

The chaperones we will study are GroEL, GroES, DnaK and Trigger factor. GroEL and GroES helps unfolded and misfolded proteins to fold correctly. DnaK helps with disaggregating and with unfolding of misfolded proteins. And Trigger factor helps the protein to remain unfolded during its synthesis.
To express the chaperones in the bacteria we will use a large plasmid containing all four chaperones and give them unique promotors, one for GroEL-GroES, one for DnaK and one for TF. The purpose of this was to easily be able to induce transcription of the specific chaperones in different combinations.

To measure our expression of these proteins we will fuse them with fluorescent proteins called E-GFP and mNeonGreen. Thereby we can measure the fluorescence to follow the expression of the fusion proteins. For every one of alzheimer - fluorescent fusion protein we will create a plasmid resulting in 4 combinations. These 4 plasmids will use a fourth promotor so that we can control this expression as well.

If we succeeds with our project we will create a model for successfully expressing these aggregate prone fusion proteins. The future of the project would then be to apply this model to other troublesome proteins and get a deeper knowledge about how the chaperones handle them.

The overview of the project is summarized in figure 1 below. As can be seen in the figure, chaperones and conditions will be tested in a screening process, with the purpose to find the best setup for further detailed studies. The detailed studies will involve modeling with systems biology, where the modeling team will give suggestions on what the laboratory team shall do to achieve the desired task. The flow of data between the laboratory and the modeling team will eventually result in the final data, with is the optimized setup for the expression of our peptides.

project flow-chart

Figure 1. An overviewing design of the project.



Sources

1. Alzheimerfonden. Alzheimers sjukdom [Internet]. Cited 2017-06-15. Available from: http://www.alzheimerfonden.se/om_demens/alzheimers_sjukdom [in swedish]
2. Alzheimer´s Disease International. Dementia statistics [Internet]. Cited 2017-06-27. Available from: https://www.alz.co.uk/research/statistics
3. Alzheimerfonden. Lexikon för Alzheimers sjukdom och andra demenssjukdomar [Internet]. Cited 2017-06-15. Available from: http://www.alzheimerfonden.se/om_demens/lexikon [in swedish]
4. Bloom GS. Amyloid-β and TauThe Trigger and Bullet in Alzheimer Disease Pathogenesis. JAMA Neurol. 2014;71(4):505-508. doi:10.1001/jamaneurol.2013.5847